ABOUT
Overview
Management
Drug Development Team
Board of Directors
Corporate Partnerships
SCIENCE
Technology Platform
Scientific Publications
PIPELINE
Overview
Piclidenoson (CF101)
Namodenoson (CF102)
CF602
Cannabinoids
INVESTORS
Overview
News & Events
Company Information
Financial Information
Stock Information
SEC Fillings
Corporate Governance
Shareholders Meetings
CONTACT
Menu
×
Scientific Publications
HOME
Scientific Publications
Growth Inhibition of Hepatocellular Carcinoma (HCC) By CBD Rich T3/C15 Cannabis Fraction Is Mediated Via the A3 Adenosine Receptor
Back